Stephen Anthony Weyel

Stephen Weyel practices at Orthopaedic & Neurosurgery Specialists in Stamford, Connecticut.

Stephen Weyel's NPI, 1922576370, was assigned on November 4, 2018. Stephen Weyel holds Connecticut license 23.004566.

Stephen Weyel's primary practice is Orthopaedic & Neurosurgery Specialists, at 5 High Ridge Park, Stamford, CT 06905 in Western Ct County. The practice phone is (203) 869-1145.

Stephen Weyel's primary practice is Orthopaedic & Neurosurgery Specialists in Stamford, Connecticut. Stephen Weyel is also affiliated with Northwell Danbury Hospital. The medical group on file is Orthopaedic and Neurosurgery Specialists. Dmand AI also links Stephen Weyel to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Stephen Weyel practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical is Stephen Weyel's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. Stephen Weyel is licensed in Connecticut.

Dmand AI lists bursitis, fibromyalgia and chronic pain, joint pain, lower back pain, muscle pain, fibromyalgia, and limb pain, muscle weakness, neck pain and spine problems and tendon and ligament injury among the conditions Stephen Weyel treats.

CMS data shows 360 Medicare services from Stephen Weyel across 9 procedure codes in 2024, for 216 Medicare patients. Medicare paid $16,588 for them.

CMS counts 216 Medicare patients who saw Stephen Weyel in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have arthritis, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Stephen Weyel's median patient age at 67, with 53% women.

In 2024, Stephen Weyel wrote 480 Medicare Part D claims for 229 patients. 96% of them were for generic drugs. CMS names the drug for 421 of them, across 10 drugs with 11 or more claims each, at $2,663 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Stephen Weyel for performance year 2024, reported as part of a group. Stephen Weyel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Stephen Weyel from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Globus Medical, Inc. paid the most, $116.